GSK plc (GLAXF)
OTCMKTS
· Delayed Price · Currency is USD
18.22
0.00 (0.00%)
Feb 21, 2025, 3:00 PM EST
GSK plc Revenue
In the year 2024, GSK plc had annual revenue of 31.38B GBP with 3.46% growth. GSK plc had revenue of 8.12B in the quarter ending December 31, 2024, with 0.81% growth.
Revenue
31.38B GBP
Revenue Growth
+3.46%
P/S Ratio
n/a
Revenue / Employee
446.88K GBP
Employees
70,212
Market Cap
73.73B USD
Revenue Chart
* This company reports financials in GBP.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 31.38B | 1.05B | 3.46% |
| Dec 31, 2023 | 30.33B | 1.00B | 3.42% |
| Dec 31, 2022 | 29.32B | 4.63B | 18.74% |
| Dec 31, 2021 | 24.70B | 342.00M | 1.40% |
| Dec 31, 2020 | 24.35B | -9.40B | -27.85% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.79B |
| SS Innovations International | 16.04M |
| Veradigm | 1.53B |
| Elite Pharmaceuticals | 70.00M |
| Glass House Brands | 188.29M |
| Northwest Biotherapeutics | 1.60M |
| BioStem Technologies | 210.49M |
| Silence Therapeutics | 21.77M |
GSK plc News
- 21 hours ago - GSK plc Sued for Securities Law Violations - Contact Levi & Korsinsky Before April 7, 2025 to Discuss Your Rights - GSK - Accesswire
- 22 hours ago - The Schall Law Firm Invites Shareholders With Losses To Join A Securities Fraud Case Against GSK plc - Accesswire
- 22 hours ago - INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in GSK plc of Class Action Lawsuit and Upcoming Deadlines - GSK - Accesswire
- 1 day ago - GSK plc Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky Before April 7, 2025 to Discuss Your Rights - GSK - Accesswire
- 1 day ago - GSK INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that GSK plc Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - Accesswire
- 1 day ago - GSK plc Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information - GSK - Accesswire
- 1 day ago - ROSEN, NATIONAL INVESTOR COUNSEL, Encourages GSK plc Investors to Secure Counsel Before Important Deadline in Securities Class Action – GSK - GlobeNewsWire
- 1 day ago - Levi & Korsinsky Notifies Shareholders of GSK plc(GSK) of a Class Action Lawsuit and an Upcoming Deadline - Accesswire